Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
Top Cited Papers
- 1 November 2004
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 364 (9447), 1757-1765
- https://doi.org/10.1016/s0140-6736(04)17398-4
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Persistence of Human Papillomavirus Infection in HIV‐Infected and ‐Uninfected Adolescent Girls: Risk Factors and Differences, by Phylogenetic TypeThe Journal of Infectious Diseases, 2004
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Human Papillomavirus Vaccines and Prevention of Cervical CancerAnnual Review of Medicine, 2004
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF 10 Line Probe AssayJournal of Clinical Microbiology, 2002
- Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotypingThe Journal of Pathology, 2001
- Short-term fluctuations in the detection of cervical human papillomavirus DNAObstetrics & Gynecology, 1996
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995